⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7789990 | 0.86 | MAPK1 (0.30) | — | |
| SCHEMBL1741558 | 0.85 | ITGB3 (0.33) | — | |
| SCHEMBL3053192 | 0.79 | — | — | |
| SCHEMBL7787819 | 0.77 | MAPK1 (0.30) | — | |
| SCHEMBL7630156 | 0.71 | — | — | |
| SCHEMBL5269896 | 0.71 | — | — | |
| SCHEMBL6712898 | 0.70 | — | — | |
| SCHEMBL23733563 | 0.67 | — | — | |
| SCHEMBL22469372 | 0.67 | — | — | |
| SCHEMBL22527339 | 0.67 | BLM (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2791135-B1 | ANABASINE DERIVATIVES TARGETING THE NICOTINIC ACETYLCHOLINE RECEPTORS | UNIV FLORIDA (US) | 2018-06-06 | — | — | EP | disclosed |
| US-9150558-B2 | Nicotine receptor targeted compounds and compositions | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-10-06 | — | — | US | disclosed |
| US-9150558-B2 | Nicotine receptor targeted compounds and compositions | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-10-06 | — | — | US | disclosed |
| US-9150558-B2 | Nicotine receptor targeted compounds and compositions | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-10-06 | — | — | US | disclosed |
| US-20140343042-A1 | NICOTINE RECEPTOR TARGETED COMPOUNDS AND COMPOSITIONS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2014-11-20 | — | — | US | disclosed |
| US-20140343042-A1 | NICOTINE RECEPTOR TARGETED COMPOUNDS AND COMPOSITIONS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2014-11-20 | — | — | US | disclosed |
| US-20140343042-A1 | NICOTINE RECEPTOR TARGETED COMPOUNDS AND COMPOSITIONS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2014-11-20 | — | — | US | disclosed |
| EP-2791135-A1 | NICOTINIC RECEPTOR TARGETED COMPOUNDS AND COMPOSITIONS | University of Florida Research Foundation (US) | 2014-10-22 | — | — | EP | disclosed |
| WO-2013090260-A1 | NICOTINIC RECEPTOR TARGETED COMPOUNDS AND COMPOSITIONS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION (US) | 2013-06-20 | — | — | WO | disclosed |
| WO-2013090260-A1 | NICOTINIC RECEPTOR TARGETED COMPOUNDS AND COMPOSITIONS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION (US) | 2013-06-20 | — | — | WO | disclosed |
| US-6071906-A | INHIBITS OR MODULATES THE INDUCIBLE ISOFORM OF NITRIC OXIDE SYNTHASE OVER THE THE CONSTITUTIVE ISOFORMS; ANTIARTHRITIC, -DIABETIC, ISCHEMIC, THROMBOSIS AGENTS; CARDIOVASCULAR DISORDERS; TOXIC SHOCK SYNDROME; AUTOIMMUNE DISEASES | G. D. SEARLE & CO. (US) | 2000-06-06 | — | — | US | disclosed |
| US-6046211-A | TREATMENT OF ARTHRITIS OR INFLAMMATORY BOWEL DISEASE, CARDIOVASCULAR ISCHEMIA, DIABETES, HYPERALGESIA (ALLODYNIA), CEREBRAL ISCHEMIA AND OTHER CNS DISORDERS | G.D. SEARLE & CO. (US) | 2000-04-04 | — | — | US | disclosed |
| EP-0968198-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE FOR INHIBITING $g(b)-AMYLOID PEPTIDE | Elan Pharmaceuticals, Inc. (US) | 2000-01-05 | — | — | EP | disclosed |
| WO-1999067221-A1 | COMPOUNDS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS | ELAN PHARMACEUTICALS, INC. (US) | 1999-12-29 | — | — | WO | disclosed |
| EP-0951466-A2 | CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS | Elan Pharmaceuticals, Inc. (US) | 1999-10-27 | — | — | EP | disclosed |
| EP-0724570-B1 | AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | SEARLE & CO (US) | 1999-03-03 | — | — | EP | disclosed |
| EP-0897912-A1 | Amidino derivatives useful as nitric oxide synthase inhibitors | G.D. SEARLE & CO. (US) | 1999-02-24 | — | — | EP | disclosed |
| WO-1998038177-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE FOR INHIBITING β-AMYLOID PEPTIDE | ELAN PHARMACEUTICALS, INC. (US) | 1998-09-03 | — | — | WO | disclosed |
| WO-1998028268-A2 | CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS AS β-AMYLOID PEPTIDE RELEASE INHIBITORS | ELAN PHARMACEUTICALS, INC. (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1995011231-A1 | AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | G. D. SEARLE & CO. (US) | 1995-04-27 | — | — | WO | disclosed |